Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial update comparing NALIRIFOX to a modified Gemcitabine, Nab-Paclitaxel, and Cisplatin regimen for locally advanced or m…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Multicenter Trial of ESK981 in Patients With Select Solid Tumors [Phase 2]
This document reports a Phase 2 multicenter clinical trial of ESK981 in select solid tumors. The study is currently recruiting across specif…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) [Phase 1]
A Phase 1 trial evaluating gemcitabine with or without pitavastatin as the primary therapy for unresectable pancreatic adenocarcinoma; curre…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation [Phase 2]
ClinicalTrials.gov update describes a Phase II randomized study (APOLLO) comparing olaparib versus placebo after curative-intent therapy in …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy [NA]
This clinical trial compares a superior mesenteric artery-first approach versus the standard approach during pancreaticoduodenectomy for pan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial of GTAEXS617 in adults with advanced solid tumors is currently recruiting. The study encompasses head and neck sq…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating ASP2138 given alone or with other cancer therapies in adults with gastric adenocarcinoma, gastroesophage…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Prospective Validation of an EHR-based Pancreatic Cancer Risk Model
Prospective validation of an electronic health record–based model to predict pancreatic cancer risk. The trial is currently active but not r…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating neoadjuvant modified FOLFIRINOX with perioperative oral hydroxychloroquine in patients with resectable p…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Sigvotatug Vedotin in Advanced Solid Tumors [Phase 1]
Phase 1 study of Sigvotatug Vedotin in advanced solid tumors is currently recruiting. The trial targets multiple indications, including non-…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer [Phase 3]
Phase 3 clinical trial evaluating the effectiveness and safety of Setidegrasib in combination with either modified FOLFIRINOX (mFOLFIRINOX) …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment [Phase 2]
Phase 2 study evaluating high-dose radiation therapy for locally advanced pancreatic adenocarcinoma that has responded to initial chemothera…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ASP546C in adults with gastric/GEJ adenocarcinoma, pancreatic adenocarcinoma, or other solid tumors is…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination of stereotactic body radiotherapy with a FAK inhibitor and a RAF/MEK inhibitor for ad…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation [Phase 1]
NT-175 is being studied in a Phase 1 trial enrolling adults with unresectable, advanced, or metastatic solid tumors positive for HLA-A*02:01…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study [NA]
This clinical trial update describes the PancStrength study, which investigates resistance training to improve physical function in patients…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients [Phase 2]
Phase 2 trial evaluating valproic acid and simvastatin with gemcitabine and nab-paclitaxel regimens in untreated metastatic pancreatic adeno…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial evaluating adding Peposertib (M3814) to radiotherapy for locally advanced pancreatic cancer is currently recruiting (Phase 1/…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial studying FOLFIRINOX with elraglusib and losartan in pancreatic adenocarcinoma, including metastatic disease. The st…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study evaluating the combination of gemcitabine hydrochloride, dasatinib, and erlotinib hydrochloride in patients with metastatic or…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating NovoTTF-200T(P) in combination with gemcitabine and nab-paclitaxel for resectable pancreatic cancer is c…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer [NA]
A clinical trial exploring the DaRT alpha radiation emitter device in combination with chemotherapy for locally advanced and metastatic panc…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating Daraxonrasib alone and in combination with gemcitabine and nab-paclitaxel as first-line therapy for meta…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial is evaluating pressurized intraperitoneal aerosolized chemotherapy (PIPAC) for peritoneal metastasis from pancreati…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1]
A Phase 1 clinical trial of PTM-101 for pancreatic ductal adenocarcinoma and related locally advanced or borderline resectable disease is cu…